GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...

T elemedicine company GoodRx ( GDRX) has been helping Americans find the cheapest way to buy drugs for years. Thanks to a new ...

(06/24 04:24) Novo Nordisk’s New Obesity Drug Beats Wegovy Weight Loss in Early Trial (06/23 19:25) Abortions Accessed Through Telemedicine Are Growing Despite Legal Challenges (06/23 19:00) ...

Novo Nordisk is teaming up with GoodRx to offer Wegovey and Ozempic for a flat price of $499 a month. Pauline Hanson reacts ...

Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.

Danish drugmaker Novo Nordisk said on Tuesday it has filed 14 new lawsuits in the United States against the sale of unapproved versions of semaglutide, the active ingredient in its popular weight ...

Second-quarter sales of the blockbuster drug soared 67% on year, despite millions of U.S. patients using generic unbranded ...

Sales for the portfolio, which includes flagship diabetes treatment Ozempic (semaglutide) and weight loss medication Wegovy (semaglutide), grew 16% to DKK 145.4bn ($22.57bn) in H1 2025.

Viking Therapeutics stock tumbled after the drugmaker released study results of its experimental weight-loss pill.

LONDON/COPENHAGEN, Aug 6 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab is facing a major challenge to its blockbuster weight-loss drug Wegovy. Sign up here. The firm, which ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.